Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE Therapy

Abstract

The presented work suggests that to achieve higher efficacy and safety for (90)Y-DOATATE therapy, both the administered amount of peptide and the activity should be optimized in treatment planning using the proposed method. This approach could also be adapted for therapy with other peptides.